Loading…

Pediatric gastroenteritis in the emergency department: practice evaluation in Belgium, France, The Netherlands and Switzerland

Based on European recommendations of ESPGHAN/ESPID from 2008, first line therapy for dehydration caused by acute gastroenteritis (AGE) is oral rehydration solution (ORS). In case of oral route failure, nasogastric tube enteral rehydration is as efficient as intra-venous rehydration and seems to lead...

Full description

Saved in:
Bibliographic Details
Published in:BMC pediatrics 2014-05, Vol.14 (1), p.125-125, Article 125
Main Authors: Pelc, Raphaëlle, Redant, Sébastien, Julliand, Sébastien, Llor, Juan, Lorrot, Mathie, Oostenbrink, Rianne, Gajdos, Vincent, Angoulvant, François
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c559t-e0e39fdb160b7522b41dbadf3629d5befca288db453bf5dc61d3db915afa0fd73
cites cdi_FETCH-LOGICAL-c559t-e0e39fdb160b7522b41dbadf3629d5befca288db453bf5dc61d3db915afa0fd73
container_end_page 125
container_issue 1
container_start_page 125
container_title BMC pediatrics
container_volume 14
creator Pelc, Raphaëlle
Redant, Sébastien
Julliand, Sébastien
Llor, Juan
Lorrot, Mathie
Oostenbrink, Rianne
Gajdos, Vincent
Angoulvant, François
description Based on European recommendations of ESPGHAN/ESPID from 2008, first line therapy for dehydration caused by acute gastroenteritis (AGE) is oral rehydration solution (ORS). In case of oral route failure, nasogastric tube enteral rehydration is as efficient as intra-venous rehydration and seems to lead to fewer adverse events. The primary objective was to describe rehydration strategies used in cases of AGE in pediatric emergency departments (PEDs) in Belgium, France, The Netherlands, and Switzerland. An electronic survey describing a scenario in which a toddler had moderate dehydration caused by AGE was sent to physicians working in pediatric emergency departments. Analytical data were analyzed with descriptive statistics and Kruskal -Wallis Rank test. We analyzed 68 responses, distributed as follows: Belgium N = 10, France N = 37, The Netherlands N = 7, and Switzerland N = 14. Oral rehydration with ORS was the first line of treatment for 90% of the respondents. In case of first line treatment failure, intravenous rehydration was preferred by 95% of respondents from France, whereas nasogastric route was more likely to be used by those from Belgium (80%), The Netherlands (100%) and Switzerland (86%). Serum electrolyte measurements were more frequently prescribed in France (92%) and Belgium (80%) than in The Netherlands (43%) and Switzerland (29%). Racecadotril was more frequently used in France, and ondansetron was more frequently used in Switzerland. No respondent suggested routine use of antibiotics. We found variations in practices in terms of invasiveness and testing. Our study supports the need for further evaluation and implementation strategies of ESPGHAN/ESPID guidelines. We plan to extend the study throughout Europe with support of the Young ESPID Group.
doi_str_mv 10.1186/1471-2431-14-125
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4045874</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A539587046</galeid><sourcerecordid>A539587046</sourcerecordid><originalsourceid>FETCH-LOGICAL-c559t-e0e39fdb160b7522b41dbadf3629d5befca288db453bf5dc61d3db915afa0fd73</originalsourceid><addsrcrecordid>eNptkt2L1DAUxYso7u7ou08SEGQfpmvSJP3wQRgX1xUGFVyfQ5rctlnaZkzSkfXBv92UWceZRQrt5eZ3TpLbkyQvCL4gpMzfEFaQNGOUpISlJOOPktN96_FBfZKceX-LMSlKlj9NTjJWxoJUp8nvr6CNDM4o1EofnIUxgDPBeGRGFDpAMIBrYVR3SMNGujBE4i3aOKmCUXF5K_tJBmPHWfAe-tZMwxJdOTkqWKKb6PAZoo_r5ag9ii_07acJv3aNZ8mTRvYent9_F8n3qw83l9fp-svHT5erdao4r0IKGGjV6JrkuC54ltWM6FrqhuZZpXkNjZJZWeqacVo3XKucaKrrinDZSNzogi6SdzvfzVQPoFW8g5O92DgzSHcnrDTieGU0nWjtVjDMeFmwaLDcGXQPZNertTCjBzcInGFeVlm5JRE_v9_P2R8T-CAG4xX08c5gJy8Ip1nFKsZm51cP0Fs7uTFOY6YKwnJKyT-qlT3EDRsbj6lmU7HitIpnxBFcJBf_oeKjYTDKjtCY2D8SvD4QdCD70HnbT_P_9Mcg3oHKWe8dNPshECzmLIo5bGIOW6xEzGKUvDyc-V7wN3z0D9xc2j4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1537146331</pqid></control><display><type>article</type><title>Pediatric gastroenteritis in the emergency department: practice evaluation in Belgium, France, The Netherlands and Switzerland</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Pelc, Raphaëlle ; Redant, Sébastien ; Julliand, Sébastien ; Llor, Juan ; Lorrot, Mathie ; Oostenbrink, Rianne ; Gajdos, Vincent ; Angoulvant, François</creator><creatorcontrib>Pelc, Raphaëlle ; Redant, Sébastien ; Julliand, Sébastien ; Llor, Juan ; Lorrot, Mathie ; Oostenbrink, Rianne ; Gajdos, Vincent ; Angoulvant, François</creatorcontrib><description>Based on European recommendations of ESPGHAN/ESPID from 2008, first line therapy for dehydration caused by acute gastroenteritis (AGE) is oral rehydration solution (ORS). In case of oral route failure, nasogastric tube enteral rehydration is as efficient as intra-venous rehydration and seems to lead to fewer adverse events. The primary objective was to describe rehydration strategies used in cases of AGE in pediatric emergency departments (PEDs) in Belgium, France, The Netherlands, and Switzerland. An electronic survey describing a scenario in which a toddler had moderate dehydration caused by AGE was sent to physicians working in pediatric emergency departments. Analytical data were analyzed with descriptive statistics and Kruskal -Wallis Rank test. We analyzed 68 responses, distributed as follows: Belgium N = 10, France N = 37, The Netherlands N = 7, and Switzerland N = 14. Oral rehydration with ORS was the first line of treatment for 90% of the respondents. In case of first line treatment failure, intravenous rehydration was preferred by 95% of respondents from France, whereas nasogastric route was more likely to be used by those from Belgium (80%), The Netherlands (100%) and Switzerland (86%). Serum electrolyte measurements were more frequently prescribed in France (92%) and Belgium (80%) than in The Netherlands (43%) and Switzerland (29%). Racecadotril was more frequently used in France, and ondansetron was more frequently used in Switzerland. No respondent suggested routine use of antibiotics. We found variations in practices in terms of invasiveness and testing. Our study supports the need for further evaluation and implementation strategies of ESPGHAN/ESPID guidelines. We plan to extend the study throughout Europe with support of the Young ESPID Group.</description><identifier>ISSN: 1471-2431</identifier><identifier>EISSN: 1471-2431</identifier><identifier>DOI: 10.1186/1471-2431-14-125</identifier><identifier>PMID: 24884619</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Abdomen - diagnostic imaging ; Age ; Analysis ; Antidiarrheals - therapeutic use ; Antiemetics - therapeutic use ; Belgium ; Blood Cell Count - utilization ; Blood Gas Analysis - utilization ; C-Reactive Protein - analysis ; Children &amp; youth ; Cross-Sectional Studies ; Data analysis ; Dehydration - etiology ; Dehydration - therapy ; Electrolytes ; Electrolytes - blood ; Emergency Service, Hospital ; Endorsements ; Epidemiology ; Feces - virology ; Fluid Therapy - methods ; France ; Gastroenteritis - complications ; Gastroenteritis - therapy ; Gastroenterology ; Hepatology ; Hospitalization ; Human health and pathology ; Humans ; Life Sciences ; Netherlands ; Nutrition ; Ondansetron - therapeutic use ; Pediatrics ; Physicians ; Practice Patterns, Physicians' - statistics &amp; numerical data ; Probiotics - therapeutic use ; Studies ; Surveys and Questionnaires ; Switzerland ; Teaching hospitals ; Thiorphan - analogs &amp; derivatives ; Thiorphan - therapeutic use ; Ultrasonography ; Urinalysis - utilization</subject><ispartof>BMC pediatrics, 2014-05, Vol.14 (1), p.125-125, Article 125</ispartof><rights>COPYRIGHT 2014 BioMed Central Ltd.</rights><rights>2014 Pelc et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>Copyright © 2014 Pelc et al.; licensee BioMed Central Ltd. 2014 Pelc et al.; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c559t-e0e39fdb160b7522b41dbadf3629d5befca288db453bf5dc61d3db915afa0fd73</citedby><cites>FETCH-LOGICAL-c559t-e0e39fdb160b7522b41dbadf3629d5befca288db453bf5dc61d3db915afa0fd73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045874/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1537146331?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,44569,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24884619$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://inserm.hal.science/inserm-02058928$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Pelc, Raphaëlle</creatorcontrib><creatorcontrib>Redant, Sébastien</creatorcontrib><creatorcontrib>Julliand, Sébastien</creatorcontrib><creatorcontrib>Llor, Juan</creatorcontrib><creatorcontrib>Lorrot, Mathie</creatorcontrib><creatorcontrib>Oostenbrink, Rianne</creatorcontrib><creatorcontrib>Gajdos, Vincent</creatorcontrib><creatorcontrib>Angoulvant, François</creatorcontrib><title>Pediatric gastroenteritis in the emergency department: practice evaluation in Belgium, France, The Netherlands and Switzerland</title><title>BMC pediatrics</title><addtitle>BMC Pediatr</addtitle><description>Based on European recommendations of ESPGHAN/ESPID from 2008, first line therapy for dehydration caused by acute gastroenteritis (AGE) is oral rehydration solution (ORS). In case of oral route failure, nasogastric tube enteral rehydration is as efficient as intra-venous rehydration and seems to lead to fewer adverse events. The primary objective was to describe rehydration strategies used in cases of AGE in pediatric emergency departments (PEDs) in Belgium, France, The Netherlands, and Switzerland. An electronic survey describing a scenario in which a toddler had moderate dehydration caused by AGE was sent to physicians working in pediatric emergency departments. Analytical data were analyzed with descriptive statistics and Kruskal -Wallis Rank test. We analyzed 68 responses, distributed as follows: Belgium N = 10, France N = 37, The Netherlands N = 7, and Switzerland N = 14. Oral rehydration with ORS was the first line of treatment for 90% of the respondents. In case of first line treatment failure, intravenous rehydration was preferred by 95% of respondents from France, whereas nasogastric route was more likely to be used by those from Belgium (80%), The Netherlands (100%) and Switzerland (86%). Serum electrolyte measurements were more frequently prescribed in France (92%) and Belgium (80%) than in The Netherlands (43%) and Switzerland (29%). Racecadotril was more frequently used in France, and ondansetron was more frequently used in Switzerland. No respondent suggested routine use of antibiotics. We found variations in practices in terms of invasiveness and testing. Our study supports the need for further evaluation and implementation strategies of ESPGHAN/ESPID guidelines. We plan to extend the study throughout Europe with support of the Young ESPID Group.</description><subject>Abdomen - diagnostic imaging</subject><subject>Age</subject><subject>Analysis</subject><subject>Antidiarrheals - therapeutic use</subject><subject>Antiemetics - therapeutic use</subject><subject>Belgium</subject><subject>Blood Cell Count - utilization</subject><subject>Blood Gas Analysis - utilization</subject><subject>C-Reactive Protein - analysis</subject><subject>Children &amp; youth</subject><subject>Cross-Sectional Studies</subject><subject>Data analysis</subject><subject>Dehydration - etiology</subject><subject>Dehydration - therapy</subject><subject>Electrolytes</subject><subject>Electrolytes - blood</subject><subject>Emergency Service, Hospital</subject><subject>Endorsements</subject><subject>Epidemiology</subject><subject>Feces - virology</subject><subject>Fluid Therapy - methods</subject><subject>France</subject><subject>Gastroenteritis - complications</subject><subject>Gastroenteritis - therapy</subject><subject>Gastroenterology</subject><subject>Hepatology</subject><subject>Hospitalization</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Netherlands</subject><subject>Nutrition</subject><subject>Ondansetron - therapeutic use</subject><subject>Pediatrics</subject><subject>Physicians</subject><subject>Practice Patterns, Physicians' - statistics &amp; numerical data</subject><subject>Probiotics - therapeutic use</subject><subject>Studies</subject><subject>Surveys and Questionnaires</subject><subject>Switzerland</subject><subject>Teaching hospitals</subject><subject>Thiorphan - analogs &amp; derivatives</subject><subject>Thiorphan - therapeutic use</subject><subject>Ultrasonography</subject><subject>Urinalysis - utilization</subject><issn>1471-2431</issn><issn>1471-2431</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptkt2L1DAUxYso7u7ou08SEGQfpmvSJP3wQRgX1xUGFVyfQ5rctlnaZkzSkfXBv92UWceZRQrt5eZ3TpLbkyQvCL4gpMzfEFaQNGOUpISlJOOPktN96_FBfZKceX-LMSlKlj9NTjJWxoJUp8nvr6CNDM4o1EofnIUxgDPBeGRGFDpAMIBrYVR3SMNGujBE4i3aOKmCUXF5K_tJBmPHWfAe-tZMwxJdOTkqWKKb6PAZoo_r5ag9ii_07acJv3aNZ8mTRvYent9_F8n3qw83l9fp-svHT5erdao4r0IKGGjV6JrkuC54ltWM6FrqhuZZpXkNjZJZWeqacVo3XKucaKrrinDZSNzogi6SdzvfzVQPoFW8g5O92DgzSHcnrDTieGU0nWjtVjDMeFmwaLDcGXQPZNertTCjBzcInGFeVlm5JRE_v9_P2R8T-CAG4xX08c5gJy8Ip1nFKsZm51cP0Fs7uTFOY6YKwnJKyT-qlT3EDRsbj6lmU7HitIpnxBFcJBf_oeKjYTDKjtCY2D8SvD4QdCD70HnbT_P_9Mcg3oHKWe8dNPshECzmLIo5bGIOW6xEzGKUvDyc-V7wN3z0D9xc2j4</recordid><startdate>20140516</startdate><enddate>20140516</enddate><creator>Pelc, Raphaëlle</creator><creator>Redant, Sébastien</creator><creator>Julliand, Sébastien</creator><creator>Llor, Juan</creator><creator>Lorrot, Mathie</creator><creator>Oostenbrink, Rianne</creator><creator>Gajdos, Vincent</creator><creator>Angoulvant, François</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope></search><sort><creationdate>20140516</creationdate><title>Pediatric gastroenteritis in the emergency department: practice evaluation in Belgium, France, The Netherlands and Switzerland</title><author>Pelc, Raphaëlle ; Redant, Sébastien ; Julliand, Sébastien ; Llor, Juan ; Lorrot, Mathie ; Oostenbrink, Rianne ; Gajdos, Vincent ; Angoulvant, François</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c559t-e0e39fdb160b7522b41dbadf3629d5befca288db453bf5dc61d3db915afa0fd73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Abdomen - diagnostic imaging</topic><topic>Age</topic><topic>Analysis</topic><topic>Antidiarrheals - therapeutic use</topic><topic>Antiemetics - therapeutic use</topic><topic>Belgium</topic><topic>Blood Cell Count - utilization</topic><topic>Blood Gas Analysis - utilization</topic><topic>C-Reactive Protein - analysis</topic><topic>Children &amp; youth</topic><topic>Cross-Sectional Studies</topic><topic>Data analysis</topic><topic>Dehydration - etiology</topic><topic>Dehydration - therapy</topic><topic>Electrolytes</topic><topic>Electrolytes - blood</topic><topic>Emergency Service, Hospital</topic><topic>Endorsements</topic><topic>Epidemiology</topic><topic>Feces - virology</topic><topic>Fluid Therapy - methods</topic><topic>France</topic><topic>Gastroenteritis - complications</topic><topic>Gastroenteritis - therapy</topic><topic>Gastroenterology</topic><topic>Hepatology</topic><topic>Hospitalization</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Netherlands</topic><topic>Nutrition</topic><topic>Ondansetron - therapeutic use</topic><topic>Pediatrics</topic><topic>Physicians</topic><topic>Practice Patterns, Physicians' - statistics &amp; numerical data</topic><topic>Probiotics - therapeutic use</topic><topic>Studies</topic><topic>Surveys and Questionnaires</topic><topic>Switzerland</topic><topic>Teaching hospitals</topic><topic>Thiorphan - analogs &amp; derivatives</topic><topic>Thiorphan - therapeutic use</topic><topic>Ultrasonography</topic><topic>Urinalysis - utilization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pelc, Raphaëlle</creatorcontrib><creatorcontrib>Redant, Sébastien</creatorcontrib><creatorcontrib>Julliand, Sébastien</creatorcontrib><creatorcontrib>Llor, Juan</creatorcontrib><creatorcontrib>Lorrot, Mathie</creatorcontrib><creatorcontrib>Oostenbrink, Rianne</creatorcontrib><creatorcontrib>Gajdos, Vincent</creatorcontrib><creatorcontrib>Angoulvant, François</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMC pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pelc, Raphaëlle</au><au>Redant, Sébastien</au><au>Julliand, Sébastien</au><au>Llor, Juan</au><au>Lorrot, Mathie</au><au>Oostenbrink, Rianne</au><au>Gajdos, Vincent</au><au>Angoulvant, François</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pediatric gastroenteritis in the emergency department: practice evaluation in Belgium, France, The Netherlands and Switzerland</atitle><jtitle>BMC pediatrics</jtitle><addtitle>BMC Pediatr</addtitle><date>2014-05-16</date><risdate>2014</risdate><volume>14</volume><issue>1</issue><spage>125</spage><epage>125</epage><pages>125-125</pages><artnum>125</artnum><issn>1471-2431</issn><eissn>1471-2431</eissn><abstract>Based on European recommendations of ESPGHAN/ESPID from 2008, first line therapy for dehydration caused by acute gastroenteritis (AGE) is oral rehydration solution (ORS). In case of oral route failure, nasogastric tube enteral rehydration is as efficient as intra-venous rehydration and seems to lead to fewer adverse events. The primary objective was to describe rehydration strategies used in cases of AGE in pediatric emergency departments (PEDs) in Belgium, France, The Netherlands, and Switzerland. An electronic survey describing a scenario in which a toddler had moderate dehydration caused by AGE was sent to physicians working in pediatric emergency departments. Analytical data were analyzed with descriptive statistics and Kruskal -Wallis Rank test. We analyzed 68 responses, distributed as follows: Belgium N = 10, France N = 37, The Netherlands N = 7, and Switzerland N = 14. Oral rehydration with ORS was the first line of treatment for 90% of the respondents. In case of first line treatment failure, intravenous rehydration was preferred by 95% of respondents from France, whereas nasogastric route was more likely to be used by those from Belgium (80%), The Netherlands (100%) and Switzerland (86%). Serum electrolyte measurements were more frequently prescribed in France (92%) and Belgium (80%) than in The Netherlands (43%) and Switzerland (29%). Racecadotril was more frequently used in France, and ondansetron was more frequently used in Switzerland. No respondent suggested routine use of antibiotics. We found variations in practices in terms of invasiveness and testing. Our study supports the need for further evaluation and implementation strategies of ESPGHAN/ESPID guidelines. We plan to extend the study throughout Europe with support of the Young ESPID Group.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>24884619</pmid><doi>10.1186/1471-2431-14-125</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-2431
ispartof BMC pediatrics, 2014-05, Vol.14 (1), p.125-125, Article 125
issn 1471-2431
1471-2431
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4045874
source Publicly Available Content Database; PubMed Central
subjects Abdomen - diagnostic imaging
Age
Analysis
Antidiarrheals - therapeutic use
Antiemetics - therapeutic use
Belgium
Blood Cell Count - utilization
Blood Gas Analysis - utilization
C-Reactive Protein - analysis
Children & youth
Cross-Sectional Studies
Data analysis
Dehydration - etiology
Dehydration - therapy
Electrolytes
Electrolytes - blood
Emergency Service, Hospital
Endorsements
Epidemiology
Feces - virology
Fluid Therapy - methods
France
Gastroenteritis - complications
Gastroenteritis - therapy
Gastroenterology
Hepatology
Hospitalization
Human health and pathology
Humans
Life Sciences
Netherlands
Nutrition
Ondansetron - therapeutic use
Pediatrics
Physicians
Practice Patterns, Physicians' - statistics & numerical data
Probiotics - therapeutic use
Studies
Surveys and Questionnaires
Switzerland
Teaching hospitals
Thiorphan - analogs & derivatives
Thiorphan - therapeutic use
Ultrasonography
Urinalysis - utilization
title Pediatric gastroenteritis in the emergency department: practice evaluation in Belgium, France, The Netherlands and Switzerland
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T22%3A21%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pediatric%20gastroenteritis%20in%20the%20emergency%20department:%20practice%20evaluation%20in%20Belgium,%20France,%20The%20Netherlands%20and%20Switzerland&rft.jtitle=BMC%20pediatrics&rft.au=Pelc,%20Rapha%C3%ABlle&rft.date=2014-05-16&rft.volume=14&rft.issue=1&rft.spage=125&rft.epage=125&rft.pages=125-125&rft.artnum=125&rft.issn=1471-2431&rft.eissn=1471-2431&rft_id=info:doi/10.1186/1471-2431-14-125&rft_dat=%3Cgale_pubme%3EA539587046%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c559t-e0e39fdb160b7522b41dbadf3629d5befca288db453bf5dc61d3db915afa0fd73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1537146331&rft_id=info:pmid/24884619&rft_galeid=A539587046&rfr_iscdi=true